placebo + ritonavir

This is a combination of a placebo and ritonavir. Ritonavir is an antiretroviral medication in the class of HIV protease inhibitors, primarily used as a pharmacokinetic enhancer (booster) for other antiretroviral drugs rather than for its own antiviral activity. It works by inhibiting the cytochrome P450 3A4 (CYP3A4) enzyme, thereby increasing plasma concentrations of co-administered drugs metabolized by this pathway. Placebo is an inert substance with no therapeutic effect, commonly used as a control in clinical trials to assess the efficacy and safety of active medications[1][2][3]. This combination may be used in clinical studies where one arm receives ritonavir and another receives placebo plus ritonavir to evaluate comparative effects.